Les modes de pratique pour la prise en charge de la maladie pulmonaire obstructive chronique en première ligne: L'étude CAGE

Keyphrases

• Chronic Obstructive Pulmonary Disease 100%
• Practice Patterns 100%
• Care Gap 100%
• Quebec 83%
• Long-acting Bronchodilators 50%
• Primary Care Practice 33%
• Severe Chronic Obstructive Pulmonary Disease 33%
• Influenza Immunization 33%
• Pulmonary Rehabilitation 33%
• Chronic Obstructive Pulmonary Disease Patient 33%
• Pharmacological Treatment 33%
• Nonprescription Drugs 33%
• Non-pharmacological Management 33%
• Smoking Cessation Counseling 33%
• Recommended Care 33%
• Hospitalization 16%
• Primary Care 16%
• Canada 16%
• Usual Care 16%
• Disease Severity 16%
• Inhaled Corticosteroids 16%
• Guideline Recommendations 16%
• Diagnosis Management 16%
• Near-optimal 16%
• Undertreatment 16%
• Mild Chronic Obstructive Pulmonary Disease 16%
• Long-acting beta-agonists 16%
• Self-reported Data 16%
• Short-acting Bronchodilators 16%
• Loss of Autonomy 16%
• β2-agonists 16%
• Prospective Cross-sectional Study 16%
• Recommended Treatment 16%

Nursing and Health Professions

• Obstructive Lung Disease 100%
• Evaluation Study 100%
• Bronchodilator 36%
• Primary Medical Care 27%
• Practice Guideline 27%
• Influenza Vaccination 18%
• Drug Therapy 18%
• Patient Referral 18%
• Pulmonary Rehabilitation 18%
• Nicotine Withdrawal 18%
• Symptom 9%
• Disease Severity 9%
• Counseling 9%
• Cross-Sectional Study 9%
• Cholinergic Receptor Blocking Agent 9%
• Beta-Adrenergic Agonist 9%

Medicine and Dentistry

• Chronic Obstructive Pulmonary Disease 100%
• Evaluation Study 100%
• Bronchodilating Agent 36%
• Primary Health Care 27%
• Influenza Vaccination 18%
• Patient Referral 18%
• Drug Therapy 18%
• Pulmonary Rehabilitation 18%
• Nicotine Withdrawal 18%
• Cross Sectional Study 9%
• Symptom 9%
• Disease Severity 9%
• Counseling 9%
• Parasympatholytic 9%
• Beta Adrenergic Receptor Stimulating Agent 9%
• Beta2 Agonist 9%